David L Conover

Title: Innovations in Breast Imaging: The Contributions of David L. Conover

Introduction

David L. Conover is a prominent inventor based in Rochester, NY, known for his significant contributions to the field of medical imaging. With a total of seven patents to his name, Conover has focused on advancing technologies that enhance the detection and diagnosis of breast cancer. His work has been instrumental in developing innovative imaging systems that improve patient outcomes.

Latest Patents

Among his latest patents, Conover has developed methods and systems for cone beam computed tomography (CBCT) imaging and image-guided procedures. One notable invention involves a CBCT device designed to output images of a patient's breast, coupled with a multi-axis transport module. This module is capable of positioning a biopsy needle within a three-dimensional frame of reference, allowing for precise targeting of lesions. Additionally, he has created a method and apparatus for cone beam breast CT image-based computer-aided detection and diagnosis. This technology utilizes advanced algorithms to enhance image quality and assist radiologists in making accurate diagnoses.

Career Highlights

Conover has had a distinguished career, working with esteemed institutions such as the University of Rochester and Koning Corporation. His expertise in medical imaging has led to groundbreaking advancements that are now utilized in clinical settings. His inventions have not only improved imaging techniques but have also contributed to the overall understanding of breast cancer detection.

Collaborations

Throughout his career, Conover has collaborated with notable colleagues, including Ruola Ning and Thomas Foster. These partnerships have fostered an environment of innovation and have played a crucial role in the development of his patented technologies.

Conclusion

David L. Conover's contributions to breast imaging technology exemplify the impact of innovation in the medical field. His patents and collaborative efforts continue to shape the future of cancer detection and diagnosis, ultimately benefiting patients and healthcare providers alike.